Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer

CMF revisited in the 21st century

(2011) E. Munzone et al.   ANNALS OF ONCOLOGY

Is gene array testing to be considered routine now?

(2011) Soonmyung Paik   BREAST

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer

(2011) Leonel F. Hernandez-Aya et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Triple-Negative Breast Cancer: An Unmet Medical Need

(2011) C. A. Hudis et al.   ONCOLOGIST

Triple-negative breast cancer--current status and future directions

(2009) O. Gluz et al.   ANNALS OF ONCOLOGY

Clinical significance of basal-like subtype in triple-negative breast cancer

(2009) Yutaka Yamamoto et al.   Breast Cancer

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

(2008) Jiyoung Rhee et al.   BMC CANCER

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH